Available information and gaps
PMID 28340339 discusses FOXO4 and the designed FOXO4-DRI peptide in cell and animal research. It is cited to distinguish the biological name from the experimental material, not to authenticate an item labelled only FOXO4.
No additional product documentation is available for this review. Publication therefore records an unresolved identity, without inferring ingredients from the name.
Similar names do not establish equivalence
FOXO4 is not automatically FOXO4-DRI. A shared name fragment does not establish amino-acid sequence, stereochemistry or terminal modifications; FOXO4-DRI findings cannot be assigned to this unidentified item.
Information still needed
- An exact substance name on the manufacturer label and documentation
- Amino-acid sequence and L/D stereochemistry if it is a peptide
- Terminal modifications, material form and traceable analytical results
Any future documents still need consistency and reliability checks; receiving them does not automatically verify the item.
What cannot be concluded
Senolytic activity, risks and human safety cannot be concluded for this unidentified item. A research publication is not an instruction or justification for personal use.
The exact product identity and authorisation remain unverified. Listing a name does not establish approval, non-approval or safety. This is not an Evidence Profile of an identified substance.
FDA describes approval as a product-specific assessment. That source provides general context; it does not mean FDA has assessed or warned about this particular named item.
Frequently asked questions
What is known about this FOXO4 entry?
The name FOXO4 does not establish whether this item is the FOXO4 protein, a FOXO4-DRI peptide or another material. This page documents an unresolved identity, not a verified senolytic or anti-aging product.
Is this FOXO4 item definitely FOXO4-DRI?
FOXO4 is not automatically FOXO4-DRI. A shared name fragment does not establish amino-acid sequence, stereochemistry or terminal modifications; FOXO4-DRI findings cannot be assigned to this unidentified item.
What information is needed to establish identity?
An exact substance name on the manufacturer label and documentation; Amino-acid sequence and L/D stereochemistry if it is a peptide; Terminal modifications, material form and traceable analytical results
Does publication establish approval or safety?
The exact product identity and authorisation remain unverified. Listing a name does not establish approval, non-approval or safety. This is not an Evidence Profile of an identified substance. Senolytic activity, risks and human safety cannot be concluded for this unidentified item. A research publication is not an instruction or justification for personal use.
Context references, not product verification
- Baar et al. · Cell 2017 · PMID 28340339
Context for distinguishing FOXO4 from FOXO4-DRI; not supplier-product evidence.
- FDA · Product-specific approval and unapproved-drug concerns
General product-assessment context; not an FDA finding about this named item.
Publication boundary
Publicly readable, but set to noindex and omitted from the search sitemap until identity can be established. This page endorses no benefit, safety claim or supplier product and provides no pricing, purchasing or usage instructions.
Educational information, not medical advice. Internal information-boundary review by PrimeCore Research Desk; external medical review pending.
Last reviewed: 2026-08-30